www.hcmena.economist.com
@EconomistEvents #hcmena
HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery
OCTOBER 13TH 2015 | MADINAT JUMEIRAH, MINA A’SALAM, DUBAI
Explore a tangible roadmap towards achieving a truly world-class health care system in the Middle East and North Africa
full GOLD color OFFICIAL SPONSORS Research Based Pharmaceutical PR AGENCY Companies Committee in Saudi
black
white ABOUT THE SUMMIT HEALTH CARE MIDDLE EAST SUMMIT How can the Middle East and North Africa deliver a truly world-class health-care system? 2014 STATISTICS The MENA region has faced a surge in demand for health care services in recent years. Shifting socio-economic factors such as increased income and better access to modern amenities have led to widespread lifestyle changes, fuelling a rise in lifestyle-related illnesses such as cancer, obesity, diabetes and heart disease. According to the World Health Organisation (WHO), non-communicable diseases will account for nearly 60% of the region’s disease burden in the next five years. The International Diabetes Federation (IDF) estimates that one in 10 adults in the Middle East region currently suffers from diabetes. It forecasts that this figure will more than double over 182 the next twenty years, reaching 68 million, or 25% of the estimated population by 2035. attendees
Join us as we bring together decision makers from the public and private sectors to explore how can the Middle East & North Africa deliver a truly world-class health care system: 62% • Hear from national and international policy makers representing the World Health Organisation, Ministry of of the audience were Education Bahrain and International Diabetes Federation. director level or above • Gain new perspectives on the future of health-care systems in the region; discuss policy, trends, tackling the talent crisis, international benchmarking and technological innovation. • Network with influential health-care stakeholders that include government, pharmaceutical, biotech, healthcare providers, suppliers, patient groups and NGOs. 100% of our audience would recommend our event to colleagues Group discounts are available for groups of 3 or more delegates. Please email the team on [email protected] or call +44 (0) 207 576 8118 for further details
SUPPORTING PUBLICATIONS SUPPORTING ORGANISATIONS SUPPORTED BY 17 countries represented PROGRAMME Tuesday October 13th 2015
09.30 OPENING REMARKS FROM THE CHAIR Vivek Muthu, Chair, Economist Intelligence Unit Healthcare, United Kingdom
09.45 KEYNOTE ADDRESS: DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTOR Amin al-Amiri, Assistant Undersecretary for Public Health Policy and License Sector, Ministry of Health, UAE 10.15 KEYNOTE ADDRESS: HIGHLIGHTING THE UAE’S COMMITMENT TO DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTOR 10.45 PANEL DISCUSSION: HEALTH CARE POLICY AND THE ROLE OF INDUSTRY: ALIGNING PUBLIC AND PRIVATE SECTOR OBJECTIVES TO DRIVE INNOVATION IN HEALTH CARE DELIVERY According to WHO statistics, the GCC has one of the highest incidences of NCDs in the world. A vast youth demographic and a rapidly ageing population, paired with vast socio-economic disparity across the region resulting in varying rates of access to health care facilities and treatments, regional governments are facing significant challenges to ensure health systems are robust, sustainable and provide quality, affordable care to all. The GCC pricing harmonisation policy, enacted throughout 2014, has been a strategic attempt to regulate pricing and improve access to medicines. However, there is debate around the efficacy of this policy many argue that price restrictions are hindering innovation and ultimately, adversely affecting patient health as well as sector growth. This session will bring together key stakeholders Excellently from government and the private sector to talk about the strategic policies guiding the future of health care in the region, identifying the main challenges to implementation, and what tangible KPIs need to be put in place to ensure a planned and collaborative approach to foster innovation and deliver world-class health care throughout the Middle East. managed event. Marwan Abdulaziz Executive Director, DuBiotech, United Arab Emirates Petra Wilson, Chief Executive Officer,International Diabetes Federation, Belgium Managing Director Sameen Siddiqi, Director, Department of Health Systems Development, Eastern Mediterranean Regional Office, World DNA Health Corp Health Organization, Egypt Samir A. Khalil, Executive Director, Middle East & Africa Pharmaceutical Research and Manufacturers of America (PhRMA) 11.45 MORNING REFRESHMENTS AND NETWORKING BREAK 12.15 PANEL DISCUSSION: EVOLVING HEALTH CARE TRENDS: IMPROVING ACCESSIBILITY, EFFICIENCY AND EFFECTIVENESS This session will provide a platform for discussion around evolving health care trends across the MENA region, including feedback on initiatives empowering primary care physicians and the growing scope of primary care centres. It will examine the role of community-centred care and ‘accessible cities’ outpatient facilities for more efficient, and accessible, treatment options for chronic illnesses, rehabilitative care, geriatric as well as examine the issue of patient accountability. |It will also evaluate regional initiatives to improve affordability and access to care such as compulsory insurance regulations, providing feedback on how these programmes are rolling out and lessons learned from a year in review as well as a discussion around how innovation is improving efficiency and effectiveness in health care delivery. A Abyad, Chief Executive Officer, Abyad Medical Center; Chairman, Middle East Academy for Medicine of Aging; Coordinator, Middle East Network on Aging; Editor, Middle East Journal of Family Medicine, Lebanon Benjamin Frank, Chief Executive Officer, Sheikh Khalifa Medical City, United Arab Emirates David Hadley, Chief Executive Officer,Mediclinic Middle East, United Arab Emirates Hisham Radwan, VP, Regional General Manager MEA, Aetna International, United Arab Emirates 13.00 INTERNATIONAL BENCHMARKING: HOW IS SINGAPORE DRIVING INNOVATION AND VALUE-GENERATION IN BIOMEDICAL R&D? Over the past twenty years, Singapore has made a concerted effort to establish itself as a global leader in biomedical R&D. This session will provide a model demonstrating the link between health care investment in R&D, skills training, manufacturing and innovation resulting in Singapore’s current position as a world-leading health care hub. Benjamin Seet, Executive Director, Biomedical Research Council, A*Star, Singapore 13.30 LUNCH 14.30 TACKLING THE TALENT CRISIS: EDUCATION AND SKILLS TRAINING FOR A SUSTAINABLE HEALTH CARE SYSTEM The Middle East is facing a severe shortage of skilled medical talent. With the major push to increase capacity in recent years leading to an ever-growing number of health care facilities, and increased demand from a growing population burdened with high rates of NCDs, the pressure is on to source qualified medical professionals. In the GCC, it is estimated that over 80% of physicians and nurses are expats. Authorities are faced with the task of encouraging MENA nationals to take roles in the burgeoning health care sector, whilst also ensuring the educational framework is in place to support further skills development. This session will explore what is being done to address the talent shortage in the health care sector and what measures need to be put in place to ensure a sustainable resource infrastructure going forward. Cameron Mirza, Head of Projects and Strategy, Secretariat-General of the Higher Education Council, Ministry of Education, Bahrain Javaid I Sheikh, Dean, Weill Cornell Medical College in Qatar; Co-Chair, Executive Committee of Qatar Academic Health It brought System; Board of Directors, Sidra Medical and Research Center, Qatar stakeholders from Rabab Diab, Deputy Chief Executive Officer and Director of Education, Health Care Accreditation Council, Jordan Sulaiman al-Emran, Deputy Secretary General, Saudi Commission for Health Specialties, Saudi Arabia all walks of life/ 15.15 PANEL DISCUSSION: TECHNOLOGICAL INNOVATION AND QUALITY OF CARE business together Patient safety, resource efficiency, affordability and accessibility are all key considerations when evaluating quality of care outcomes. Advancements in medical technologies and ICT mean that health care systems and providers are better Director able to treat and care for patients, with the added benefit of improving efficiencies and reducing costs. This session will UNAIDS delve into the role of innovation in how we collect, manage and analyse patient data, as well as evaluate the latest technological innovations allowing for more affordable, higher quality care in the MENA region. •How is technology improving patient-centricity and patient outcomes? •What role does technological innovation play in attracting private investment into the health care sector? Bern Shen, Chief Medical Officer, HealthCrowd; Board Member, TechWadi, United Arab Emirates Gareth Sherlock, Chief Information Officer,Cleveland Clinic, Abu Dhabi Helmut M. Schuehsler, Chairman and Chief Executive Officer, TVM Capital Healthcare, UAE 16.00 CLOSING KEYNOTE: THE FUTURE OF HEALTH CARE: FOCUS ON THE PATIENT EXPERIENCE Hear from this world-leader in health care on the trends and innovations that are best serving patients. David Hayes, Medical Director, Mayo Clinic, United States 16.30 CLOSING REMARKS AND END OF CONFERENCE CONFIRMED SPEAKERS INCLUDE:
VIVEK MUTHU A ABYAD MARWAN ABDULAZIZ Chief Executive Officer, Chair Abyad Medical Center; Executive Director Economist Intelligence Unit Chairman, DuBiotech Healthcare Middle East Academy for Medicine of Aging; United Kingdom Coordinator United Arab Emirates Middle East Network on Aging; Editor Middle East Journal of Family Medicine Lebanon
BENJAMIN FRANK DAVID HADLEY DAVID HAYES Chief Executive Officer Chief Executive Officer Medical Director Sheikh Khalifa Medical City Mediclinic Middle East Mayo Clinic United Arab Emirates United Arab Emirates United States
SAMIR A. KHALIL CAMERON MIRZA HISHAM RADWAN, Executive Director, Middle East Head of Projects and Strategy, VP, Regional General Manager & Africa Secretariat-General of the MEA Pharmaceutical Research and Higher Education Council Aetna International Manufacturers of America Ministry of Education United Arab Emirates (PhRMA) Bahrain
BENJAMIN SEET JAVAID I SHEIKH BERN SHEN Executive Director Dean, Chief Medical Officer, Weill Cornell Medical College in Biomedical Research Council Qatar; HealthCrowd; A*Star Co-Chair, Board Member Executive Committee of Qatar Singapore Academic Health System; TechWadi Board of Directors, United Arab Emirates Sidra Medical and Research Center Qatar
SAMEEN SIDDIQI GARETH SHERLOCK PETRA WILSON Director, Department of Health Chief Information Officer Chief Executive Officer Systems Development, Eastern Cleveland Clinic International Diabetes Mediterranean Regional Office Abu Dhabi Federation World Health Organization Belgium Egypt
Sponsorship opportunities are available. Please contact Kay Westmoreland on +971 4433 4208 or email [email protected]. 2014 ATTENDING COMPANIES INCLUDED: • 7 Days • Economist Intelligence Unit • Middle East Health Magazine • Abbott Laboratories • Edelman • Moorland Gray Executive Search • AbbVie BioPharmaceuticals GmBH • Eli Lilly and Company • Mundipharma • ABC Dubai • Emmahim Global Network Link • NGC Medical • Abu Dhabi National Insurance • Falcon and Associates • NMC Healthcare Company • GE Healthcare • Novartis • Aegis Capital • Grayling • Now Health International • Aetna • GSK • Oracle Middle East and North • Al Mariya Polyclinic • Gulf News Africa • Al Noor Hospital • Health Authority of Abu Dhabi • Pfizer • AlSharq Health Care Member of • Health Beyond Borders • Pharmax Pharmaceuticals FZ Fujairah • Healthcare Industry Service Center • Philips • National Group • Hoffmann-La Roche Ltd • PhRMAG • American Hospital • ICME International • Prime Minister’s Office, UAE • Anglo Arabian Healthcare • Janssen Gulf • Quanteus • Arya Insurance Brokerage • Johns Hopkins Aramco Healthcare • RAK Hospital Company • Joint Commission International • Sanofi • AstraZeneca • Julphar • Saudi Aramco • Atlas Medical Technologies • KARL STORZ - ENDOSKOPE East • Shane Phillips Consultants • Axa Insurance Mediterranean Gulf • Sheikh Khalifa Medical City • Bait Al Batterjee Holding Company • King Hussein Cancer Foundation • Siegel+Gale • Bayer Healthcare • King Saud bin Abdulaziz University • Spengler Fox • Bennett Jones • Kleos Healthcare Corporation • Supreme Council of Health • BeUtiful You • Kuwait News Agency (KUNA) • Taha Actuaries & Consultants • BLI • Leo Pharma • Takeda • Boehringer Ingelheim • Les Laboratoires Servier - Gulf • Tawam Hospital • Bristol-Myers Squibb Region • TECOM Investments • Burjeel Hospital • Lux Actuaries and Consultants • The Gulf Today • CAIN • Mafraq Hospital- SEHA • The National • ClinArt International • Manchester Clinic Jumeriah • Thomson Reuters • Clinart MENA • MD Lifeline Hospital • U N CARGO & LOGISTIC • Dar Al Khaleej • MedDrop GmbH • Vision Executive Search • DNA Health Corp • Mediclinic City Hospital Dubai • vps healthcare • Dubai Eye 103.8 • MEED • Dubai Health Authority • Menasa and Partners • DuBiotech • Merck Sharp & Dohme HEALTH CARE MIDDLE EAST AND NORTH AFRICA October 13th 2015 - Madinat Jumeirah, Mina A’Salam Hotel, Dubai, UAE DELEGATE FEES (PER PERSON) HOW TO REGISTER
Category Standard Rate Quantity Total ONLINE www.hcmena.economist.com EMAIL [email protected] Pharmaceutical & Biotech Companies $900.00 CALL US +44 (0) 20 7576 8118 Health Care Providers $675.00 FAX +44 (0) 20 7576 8472
Subscribers to The Economist $720.00 POST The Economist Events, Customer Service EMEA, 20 Cabot Square, Canary Wharf, London E14 4QW, UK Gov/NGOs/public sector $540.00 DATA PROTECTION Discounts are available for groups of 3 or more delegates. Total Please email the team on [email protected] The Economist Events is part of The Economist Group. Occasionally, the or call +44 (0) 207 576 8118 for further details companies in The Economist Group would like to contact you about new features, events, news, special offers and for market research purposes.
DELEGATE DETAILS Tick this box if you’d like to hear from us by e-mail We’ll assume that we may contact you unless you tick these boxes: First Name (Dr/Mr/Mrs/Ms) Surname No contact from us by post No contact from us by telephone Job Title Industry Sector No contact from other selected companies about their products and services by post Company The Economist Group is a global organisation and operates a strict privacy Address policy around the world. To read more about us and our privacy policy please go to www.economistgroup.com/privacy Town/city Postcode Country
Tel Fax Email TERMS AND CONDITIONS
Your delegate fee should be paid in full prior to attendance. If payment has not been received you will not be permitted to enter the event. Cancellations: Should you not Payment methods (delegates fee(s) strictly payable in advance) be able to attend the event, substitutions can be made at no extra charge up until the event. If a suitable replacement cannot be found, then an administration fee of Credit Card (tick as appropriate): Amex Visa Mastercard 20% will be incurred for cancellations received more than 21 days prior to an event. When a cancellation is made less than 21 days prior to an event, the registered Name as it appears on card: delegate is liable for full payment of the fee. Economist Events reserve the right to Card No. Expiry date: / 3/4 digital security number: change the programme if necessary. Bank transfer Payable to Barclays Bank Plc, please quote ref: EM1342 and send a copy of the instructions together with your registration form. CONFIRMATION Account Name: The Economist Intelligence Unit. Account Number:54609155, Sort Code: 20-67-59. IBAN: GB09BARC20675954609155 Swift address: BARCGB22 I confirm that I have read and accepted The Economist Events’ terms and We require an invoice to raise payment (Bookings with requests for bank tranfsers and invoices conditions policy and I am authorised to sign this document on behalf of the should be received before September 12th 2015.) Please complete below if the billing contact is not the registered delegate. above company. Billing contact: PO number (if required): Signature: Date: Billing address (if different from the Organisation address):